title: Alcohol and polysubstance abuse among women.
abstract: A review of the literature in this relatively new field highlights the legitimacy of gender-specific research on substance abuse in women. Consistent findings compared to men include a higher physical vulnerability to alcohol, a higher risk of assortative mating, the reported association of traumatic events with the onset of substance abuse, a higher psychiatric comorbidity and a shorter interval between first problem and first treatment episode. Intravenous drug use remains the major source of growth of HIV infection among women. Family assessment and treatment as well as the involvement of female role models are critical to the recovery process. Gender-specific services may be recruiting women who might not otherwise have sought treatment for their substance abuse. Further investigation is required in order to distinguish the relative significance of the genetic versus environmental vulnerability of women, the impact of rapidly changing social mores on the onset, pattern and course of substance abuse, possible gender-specific alcohol typologies, the validity of the recall of traumatic events as well as the program variables required in reaching out and engaging women on the path to recovery.
authors.affiliation: Department of Psychiatry, University of Calgary, Alberta.
authors.forename: N
authors.initials: N
authors.lastname: el-Guebaly
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000235:genetics / Q000523:psychology / Q000534:rehabilitation*; D016241:Child of Impaired Parents / Q000523:psychology; D005260:Female; D005783:Gender Identity; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D013287:Illicit Drugs; D011619:Psychotropic Drugs; D012307:Risk Factors; D012931:Social Environment; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000523:psychology / Q000534:rehabilitation; D019966:Substance-Related Disorders / Q000235:genetics / Q000523:psychology / Q000534:rehabilitation*
chemical_list: D013287:Illicit Drugs; D011619:Psychotropic Drugs